Boehringer Ingelheim GmbH, the German family-owned drugmaker, agreed to pay $650 million to settle the majority of lawsuits filed over its blood thinner Pradaxa, which has been linked to more than 500 patient deaths.
Boehringer, slated to face the first U.S. trial in September of claims there was no antidote to stop bleed-out deaths among Pradaxa patients, is seeking to resolve about 4,000 suits, company officials said in a statement today. That would provide an average per-case payout of $162,500.
19:43 Citing 'Racial Stereotype,' Supreme Court Says Texas Inmate Can Appeal Death Sentence14
21:07 Heart, lung problems may not always need ICU care27
04:50 New Zealand judge upholds Kim Dotcom extradition ruling16
17:41 Norma McCorvey, Jane Roe of the Roe v. Wade Supreme Court case that legalized abortion, dead at 6913